Literature DB >> 3091928

Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction.

E A Kvittingen, E Jellum, O Stokke, A Flatmark, A Bergan, G Sødal, S Halvorsen, E Schrumpf, E Gjone.   

Abstract

Orthotopic liver transplantation was performed on a 23-year-old female with hereditary tyrosinaemia. The disorder was diagnosed at 7 years of age due to severe rickets, and the patient was treated with a diet restricted in phenylalanine and tyrosine. Nineteen months before the transplantation she had an acute episode of diffuse gastrointestinal bleeding due to portal hypertension. Three subsequent bleeding episodes with accompanying ascites and signs of encephalopathy were considered life-threatening. Nine months after the liver transplantation the patient is well, but serum transaminases are slightly elevated. Without dietary restrictions serum tyrosine and inorganic phosphate are normalized, no succinylacetone can be detected in serum, and urinary excretion of p-hydroxyphenyllactate and p-hydroxyphenylpyruvate is normal. Excretion of amino acids, glucose and beta 2-microglobulin decreased significantly after the transplantation but is still elevated. The succinylacetone concentration in urine is about 20% of the preoperative level. After an oral tyrosine load, succinylacetone excretion increased sevenfold but no deterioration of the renal tubular function was observed and no tyrosine metabolites were detectable in serum. The findings indicate that the defective tyrosine metabolism occurs in the kidneys, but does not produce tubular dysfunction. The residual tubular dysfunction of the patient is probably due to irreversible damage of the tubular epithelium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091928     DOI: 10.1007/bf01799465

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  13 in total

Review 1.  Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma.

Authors:  T E Starzl; B J Zitelli; B W Shaw; S Iwatsuki; J C Gartner; R D Gordon; J J Malatuck; I J Fox; A H Urbach; D H Van Thiel
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

2.  Homotransplantation of the liver in a patient with hepatoma and hereditary tyrosinemia.

Authors:  R O Fisch; E R McCabe; D Doeden; L J Koep; J G Kohlhoff; A Silverman; T E Starzl
Journal:  J Pediatr       Date:  1978-10       Impact factor: 4.406

3.  Studies on the metabolism of the phenolic acids in hereditary tyrosinemia by a gas-liquid chromatographic method.

Authors:  J Gentz; B Lindblad; S Lindstedt; R Zetterström
Journal:  J Lab Clin Med       Date:  1969-08

4.  Maleic acid-induced inhibition of amino acid transport in rat kidney.

Authors:  L E Rosenberg; S Segal
Journal:  Biochem J       Date:  1964-08       Impact factor: 3.857

5.  A study of the determination of 5-aminolevulinate hydro-lyase (delta-aminolevulinate dehydratase) activity in hemolysates of human erythrocytes.

Authors:  H B Collier
Journal:  Clin Biochem       Date:  1971-12       Impact factor: 3.281

6.  The occurrence of hepatoma in the chronic form of hereditary tyrosinemia.

Authors:  A G Weinberg; C E Mize; H G Worthen
Journal:  J Pediatr       Date:  1976-03       Impact factor: 4.406

7.  Dietary treatment in tyrosinemia (tyrosinosis). With a note on the possible recognition of the carrier state.

Authors:  J Gentz; B Lindblad; S Lindstedt; L Levy; W Shasteen; R Zetterstrom
Journal:  Am J Dis Child       Date:  1967-01

8.  Persistent succinylacetone excretion after liver transplantation in a patient with hereditary tyrosinaemia type I.

Authors:  M Tuchman; D K Freese; H L Sharp; C B Whitley; M L Ramnaraine; R A Ulstrom; J S Najarian; N Ascher; N R Buist; A B Terry
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

9.  Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinemia.

Authors:  E A Kvittingen; S Halvorsen; E Jellum
Journal:  Pediatr Res       Date:  1983-07       Impact factor: 3.756

10.  On the enzymic defects in hereditary tyrosinemia.

Authors:  B Lindblad; S Lindstedt; G Steen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

View more
  13 in total

1.  Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up.

Authors:  L J W M Pierik; F J van Spronsen; C M A Bijleveld; C M L van Dael
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Hepatocellular carcinoma despite long-term survival in chronic tyrosinaemia I.

Authors:  S Z Kim; K G Kupke; L Ierardi-Curto; E Holme; J Greter; R M Tanguay; J Poudrier; M D'Astous; F Lettre; S H Hahn; H L Levy
Journal:  J Inherit Metab Dis       Date:  2000-12       Impact factor: 4.982

3.  Liver transplantation for tyrosinemia. A review of 10 cases from the University of Pittsburgh.

Authors:  L A Mieles; C O Esquivel; D H Van Thiel; B Koneru; L Makowka; A G Tzakis; T E Starzl
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

4.  Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.

Authors:  M Grompe; K Overturf; M al-Dhalimy; M Finegold
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

Review 5.  Current strategies for the treatment of hereditary tyrosinemia type I.

Authors:  Merja Ashorn; Sari Pitkänen; Matti K Salo; Markku Heikinheimo
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

6.  Renal failure in adult patients with hereditary tyrosinaemia type I.

Authors:  E A Kvittingen; T Talseth; S Halvorsen; C Jakobs; T Hovig; A Flatmark
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

7.  Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1.

Authors:  M D Bain; P Purkiss; M Jones; P Bingham; T E Stacey; R A Chalmers
Journal:  Eur J Pediatr       Date:  1990-06       Impact factor: 3.183

8.  Visceral pathology of hereditary tyrosinemia type I.

Authors:  P Russo; S O'Regan
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

Review 9.  Tyrosinaemia type I--an update.

Authors:  E A Kvittingen
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 10.  Treatment of inherited metabolic disorders by liver transplantation.

Authors:  M Burdelski; B Rodeck; A Latta; K Latta; J Brodehl; B Ringe; R Pichlmayr
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.